These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15345309)

  • 1. The induction of eosinophil peroxidase release: improved methods of measurement and stimulation.
    Adamko DJ; Wu Y; Gleich GJ; Lacy P; Moqbel R
    J Immunol Methods; 2004 Aug; 291(1-2):101-8. PubMed ID: 15345309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The measurement of superoxide generation and eosinophil peroxidase (EPO) from eosinophils].
    Okada C; Soda R; Takahashi K
    Nihon Rinsho; 1993 Mar; 51(3):730-5. PubMed ID: 8388065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation.
    Lamkhioued B; Gounni AS; Gruart V; Pierce A; Capron A; Capron M
    Eur J Immunol; 1995 Jan; 25(1):117-25. PubMed ID: 7843220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
    Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
    Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic granuloma of the bone in Hand-Schüller-Christian disease: extensive in vivo eosinophil degranulation and subsequent binding of released eosinophil peroxidase (EPO) to other inflammatory cells.
    Zabucchi G; Soranzo MR; Menegazzi R; Cattin L; Vecchio M; Lanza F; Patriarca P
    J Pathol; 1991 Mar; 163(3):225-31. PubMed ID: 1707451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular release of rat eosinophil peroxidase (EPO) I. Role of anaphylactic immunoglobulins.
    Khalife J; Capron M; Grzych JM; Bazin H; Capron A
    J Immunol; 1985 Mar; 134(3):1968-74. PubMed ID: 3968436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effect of AS-35. a novel antiallergic drug, on chemical mediator release from human eosinophils].
    Kawashima T; Nagaki S; Iwakaji A; Iwamoto I; Yoshida S; Tomioka H
    Arerugi; 1994 Dec; 43(11):1326-30. PubMed ID: 7887808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen extracts directly mobilize and activate human eosinophils.
    Svensson L; Rudin A; Wennerås C
    Eur J Immunol; 2004 Jun; 34(6):1744-51. PubMed ID: 15162445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual influence between eosinophil peroxidase (EPO) and neutrophils: neutrophils reversibly inhibit EPO enzymatic activity and EPO increases neutrophil adhesiveness.
    Zabucchi G; Menegazzi R; Cramer R; Nardon E; Patriarca P
    Immunology; 1990 Apr; 69(4):580-7. PubMed ID: 2335377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of stimulated eosinophil degranulation by VLA-4 (CD49d)-mediated adhesion to fibronectin.
    Neeley SP; Hamann KJ; Dowling TL; McAllister KT; White SR; Leff AR
    Am J Respir Cell Mol Biol; 1994 Aug; 11(2):206-13. PubMed ID: 8049081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterol.
    Muñoz NM; Rabe KF; Vita AJ; McAllister K; Mayer D; Weiss M; Leff AR
    J Pharmacol Exp Ther; 1995 May; 273(2):850-4. PubMed ID: 7752089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human eosinophil peroxidase: purification and characterization.
    Carlson MG; Peterson CG; Venge P
    J Immunol; 1985 Mar; 134(3):1875-9. PubMed ID: 3918110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of eosinophil peroxidase release by chymotrypsin type protease inhibitors from activated human eosinophils].
    Kawaji K; Matsunaga Y; Kido H; Ogura T
    Arerugi; 1993 Oct; 42(10):1591-9. PubMed ID: 8250722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult deposition of eosinophil peroxidase in a subset of human breast carcinomas.
    Samoszuk MK; Nguyen V; Gluzman I; Pham JH
    Am J Pathol; 1996 Mar; 148(3):701-6. PubMed ID: 8774125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil peroxidase is detectable with a monoclonal antibody in collagen bands of nodular sclerosis Hodgkin's disease.
    Samoszuk M; Sholly S; Epstein AL
    Lab Invest; 1987 Apr; 56(4):394-400. PubMed ID: 3550288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory mechanism of eosinophil peroxidase release from guinea pig eosinophils.
    Kirino Y; Mio M; Kamei C
    Jpn J Pharmacol; 2000 Aug; 83(4):293-9. PubMed ID: 11001174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells.
    Davoine F; Cao M; Wu Y; Ajamian F; Ilarraza R; Kokaji AI; Moqbel R; Adamko DJ
    J Allergy Clin Immunol; 2008 Jul; 122(1):69-77, 77.e1-2. PubMed ID: 18472150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of human eosinophil peroxidase by human neutrophils.
    Zabucchi G; Menegazzi R; Soranzo MR; Patriarca P
    Am J Pathol; 1986 Sep; 124(3):510-8. PubMed ID: 3020987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Induction of granule release by intracellular application of Ca and GTP gamma S in human eosinophils].
    Aizawa T; Kakuta Y; Tamura G; Shirato K
    Nihon Rinsho; 1993 Mar; 51(3):620-5. PubMed ID: 8492434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion-dependent interactions between eosinophils and cholinergic nerves.
    Kingham PJ; McLean WG; Sawatzky DA; Walsh MT; Costello RW
    Am J Physiol Lung Cell Mol Physiol; 2002 Jun; 282(6):L1229-38. PubMed ID: 12003778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.